ベータ
治験レーダーAI

糖尿病の治験を表示しています。

健康状態や治療法を理解し、近くの治験を探すお手伝いができます。
私たちの検索ツールは英語のみをサポートしています。他の言語で検索と議論するには、上の治験レーダーを使用するか、以下の疾患と場所のフィルターを選択してください。
30 結果
  
疾患名
糖尿病
×
 
試験タイトル
状況
Clinical Trial to Evaluate the Efficacy and Safety of DA-5218 in Patients With Type 2 Diabetes NCT07229534
募集準備中
Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control NCT07239440
募集準備中
Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing Metformin Monotherapy in Patients with Type 2 Diabetes Who Have Inadequate Glycemic Control NCT05743907
完了
Study to Evaluate Safety and PK/PD of DA-3091 in Healthy Male Subjects (SR-Exenatide) NCT01156779
完了
Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 Diabetes NCT02949193
完了
Observational Study to Evaluate the Efficacy and Safety of Suganon Tab. or Sugamet XR Tab. NCT04326166
状況不明
A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin NCT02946541
完了
A Study to Evaluate the Safety, Tolerability, PK and PD of DA-1241 in Healthy Male Subjects and Subjects With T2DM NCT03646721
完了
A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male Subjects NCT03061981
完了
A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01(Evogliptin/Metformin XR 2.5/500 mg x 2 Tablets) Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg in Healthy Male Volunteers NCT02375139
完了
A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01 Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg, and to Evaluate the Effect of Food on the Pharmacokinetics of DA-1229_01 in Healthy Male Volunteers NCT02167061
完了
Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of DA-1229 and Metformin After Oral Administration in Healthy Male Subjects NCT01941199
完了
Efficacy and Safety of Evogliptin When Added to Ongoing Metformin and Dapagliflozin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control NCT04170998
完了
Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN) NCT02974504
完了
A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH) NCT06627322
募集中
Efficacy and Safety of DA5221-T When Added to Ongoing DA5221-B1 and DA5221-B2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control NCT06290349
実施中／登録終了
Efficacy and Safety of Dapagliflozin When Added to Ongoing Metformin and Evogliptin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control NCT04356742
完了
A Study to Investigate the Bioequivalence Test of DA-1229_01(A) at Fed State NCT03944200
完了
A Study to Investigate the Bioequivalence Test of DA-1229_01(A) at Fasting State NCT03939143
完了
Pharmacokinetic and Pharmacodynamic Drug-Drug Interaction of Evogliptin and Empagliflozin or Dapagliflozin in Healthy Male Adults NCT03766724
完了
Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5mg and Glimepiride 4mg NCT02954822
完了
Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5 mg and Pioglitazone 30 mg NCT02753803
完了
A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mg NCT04653779
状況不明
A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and Dapagliflozin (EVOMETA) NCT04706637
状況不明
A Study to Characterize the Pharmacokinetics/Pharmacodynamics and Effect of Food of DA-1229 in Healthy Male Subjects NCT00961025
状況不明
Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases NCT03910361
完了
A Study to Evaluate the Safety of DA-3030 and to Explore the Efficacy for Diabetic Neuropathic Pain NCT01820715
完了
Study of DA-9801 to Treat Diabetic Neuropathic Pain NCT01813799
完了
Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic Dysfunction NCT02754219
完了
Study of DA-9801 to Treat Diabetic Neuropathy NCT01822925
完了結果公開